Biology of Blood and Marrow Transplantation
Volume 12, Issue 2 , Pages 226-234 , February 2006

Gastrointestinal Graft-versus-Host Disease in Recipients of Autologous Hematopoietic Stem Cells: Incidence, Risk Factors, and Outcome

  • Leona Holmberg

      Affiliations

    • Medical Oncology, Clinical Research Division, Fred Hutchinson Cancer Research Center and the University of Washington School of Medicine, Seattle, Washington
    • ,
  • Kaoru Kikuchi

      Affiliations

    • Gastroenterology/Hepatology, Clinical Research Division, Fred Hutchinson Cancer Research Center and the University of Washington School of Medicine, Seattle, Washington
    • ,
  • Ted A. Gooley

      Affiliations

    • Clinical Statistics Sections, Clinical Research Division, Fred Hutchinson Cancer Research Center and the University of Washington School of Medicine, Seattle, Washington
    • ,
  • Kristina M. Adams

      Affiliations

    • Human Immunogenetics, Clinical Research Division, Fred Hutchinson Cancer Research Center and the University of Washington School of Medicine, Seattle, Washington
    • ,
  • David M. Hockenbery

      Affiliations

    • Gastroenterology/Hepatology, Clinical Research Division, Fred Hutchinson Cancer Research Center and the University of Washington School of Medicine, Seattle, Washington
    • ,
  • Mary E.D. Flowers

      Affiliations

    • Medical Oncology, Clinical Research Division, Fred Hutchinson Cancer Research Center and the University of Washington School of Medicine, Seattle, Washington
    • ,
  • H. Gary Schoch

      Affiliations

    • Clinical Statistics Sections, Clinical Research Division, Fred Hutchinson Cancer Research Center and the University of Washington School of Medicine, Seattle, Washington
    • ,
  • William Bensinger

      Affiliations

    • Medical Oncology, Clinical Research Division, Fred Hutchinson Cancer Research Center and the University of Washington School of Medicine, Seattle, Washington
    • ,
  • George B. McDonald

      Affiliations

    • Gastroenterology/Hepatology, Clinical Research Division, Fred Hutchinson Cancer Research Center and the University of Washington School of Medicine, Seattle, Washington
    • Corresponding Author InformationCorrespondence: George B. McDonald, MD, Gastroenterology/Hepatology Section (D2-190), Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue North, P.O. Box 19024, Seattle, WA 98109-1024.

Received 2 August 2005 ,Accepted 7 October 2005.

References 

  1. Sullivan KM . Graft-versus-host disease . In:  Blume KG ,  Forman SJ ,  Appelbaum FR editor. Thomas’ Hematopoietic Cell Transplantation . 3rd ed.. Malden, MA: Blackwell Scientific Publications; 2004;
  2. Martin PJ , McDonald GB , Sanders JE , et al.   Increasingly frequent diagnosis of acute graft-versus-host disease after allogeneic hematopoietic cell transplantation . Biol Blood Marrow Transplant . 2004;10:320–327
  3. Gluckman E , Devergie A , Sohier J , et al.   Graft-versus-host disease in recipients of syngeneic bone marrow . Lancet . 1980;1:253–254
  4. Einsele H , Ehninger G , Hebart H , et al.   Incidence of local CMV infection and acute intestinal GVHD in marrow transplant recipients with severe diarrhoea . Bone Marrow Transplant . 1994;14:955–963
  5. Adams KM , Holmberg LA , Leisenring W , et al.   Risk factors for syngeneic graft-versus-host disease after adult hematopoietic cell transplantation . Blood . 2004;104:1894–1897
  6. Einsele H , Ehninger G , Schneider EM , et al.   High frequency of graft-versus-host-like syndromes following syngeneic bone marrow transplantation . Transplantation . 1988;45:579–585
  7. Thein SL , Goldman JM , Galton DAG . Acute “graft-versus-host disease” after autografting for chronic granulocytic leukemia in transformation . Ann Intern Med . 1981;94:210–211
  8. Hood AF , Vogelsang GB , Black LP , et al.   Acute graft-versus-host disease (development following autologous and syngeneic bone marrow transplantation) . Arch Dermatol . 1987;123:745–750
  9. Jones RJ , Vogelsang GB , Hess AD , et al.   Induction of graft-versus-host disease after autologous bone marrow transplantation . Lancet . 1989;i:754–757
  10. Carella AM , Gaozza E , Congiu A , et al.   Cyclosporine-induced graft-versus-host disease after autologous bone marrow transplantation in hematological malignancies . Ann Hematol . 1991;62:156–159
  11. Baron F , Gothot A , Salmon JP , et al.   Clinical course and predictive factors for cyclosporin-induced autologous graft-versus-host disease after autologous haematopoietic stem cell transplantation . Br J Haematol . 2000;111:745–753
  12. Tzung S-P , Hackman RC , Hockenbery DM , et al.   Lymphocytic gastritis resembling graft-vs.-host disease following autologous hematopoietic cell transplantation . Biol Blood Marrow Transplant . 1998;4:43–48
  13. Saunders MD , Shulman HM , Murakami CS , et al.   Bile duct apoptosis and cholestasis resembling acute graft-versus-host disease after autologous hematopoietic cell transplantation . Am J Surg Pathol . 2000;24:1004–1008
  14. Angelucci E , Brittenham GM , McLaren CE , et al.   Hepatic iron concentration and total body iron stores in thalassemia major . N Engl J Med . 2000;343:327–331
  15. Hess A , Jones R . Autologous graft-vs.-host disease . In:  Blume K ,  Forman SJ ,  Appelbaum F editor. Thomas’ Hematopoietic Cell Transplantation . 3rd ed.. Malden, MA: Blackwell Scientific Publishing; 2004;p. 405–413
  16. Schiffman KS , Bensinger WI , Appelbaum FR , et al.   Phase II study of high-dose busulfan, melphalan and thiotepa with autologous peripheral blood stem cell support in patients with malignant disease . Bone Marrow Transplant . 1996;17:943–950
  17. Brunvand MW , Bensinger WI , Soll E , et al.   High-dose fractionated total-body irradiation, etoposide and cyclophosphamide for treatment of malignant lymphoma (comparison of autologous bone marrow and peripheral blood stem cells) . Bone Marrow Transplant . 1996;18:131–141
  18. Gopal AK , Rajendran JG , Petersdorf SH , et al.   High-dose chemo-radioimmunotherapy with autologous stem cell support for relapsed mantle cell lymphoma . Blood . 2002;99:3158–3162
  19. Boeckh M , Stevens-Ayers T , Bowden RA . Cytomegalovirus pp65 antigenemia after autologous marrow and peripheral blood stem cell transplantation . J Infect Dis . 1996;174:907–912
  20. Strasser SI , McDonald GB . Gastrointestinal and hepatic complications . In:  Blume KG ,  Forman SJ ,  Appelbaum FR editor. Thomas’ Hematopoietic Cell Transplantation . 3rd ed.. Malden, MA: Blackwell Scientific Publications; 2004;p. 769–810
  21. Spencer GD , Hackman RC , McDonald GB , et al.   A prospective study of unexplained nausea and vomiting after marrow transplantation . Transplantation . 1986;42:602–607
  22. Wu D , Hockenbery DM , Brentnall TA , et al.   Persistent nausea and anorexia after marrow transplantation (a prospective study of 78 patients) . Transplantation . 1998;66:1319–1324
  23. Cox GJ , Matsui SM , Lo RS , et al.   Etiology and outcome of diarrhea after marrow transplantation (a prospective study) . Gastroenterology . 1994;107:1398–1407
  24. Hackman RC , Wolford JL , Gleaves CA , et al.   Recognition and rapid diagnosis of upper gastrointestinal cytomegalovirus infection in marrow transplant recipients (a comparison of seven virologic methods) . Transplantation . 1994;57:231–237
  25. Ponec RJ , Hackman RC , McDonald GB . Endoscopic and histologic diagnosis of intestinal graft-vs.-host disease after marrow transplantation . Gastrointest Endosc . 1999;49:612–621
  26. Snover DC , Weisdorf SA , Vercellotti GM , et al.   A histopathologic study of gastric and small intestine graft-versus-host disease following allogeneic bone marrow transplantation . Hum Pathol . 1985;16:387–392
  27. Washington K , Bentley RC , Green A , et al.   Gastric graft-versus-host disease (a blinded histologic study) . Am J Surg Pathol . 1997;21:1037–1046
  28. Weisdorf DJ , Snover DC , Haake R , et al.   Acute upper gastrointestinal graft-versus-host disease (clinical significance and response to immunosuppressive therapy) . Blood . 1990;76:624–629
  29. Holmberg LA , Boeckh M , Hooper H , et al.   Increased incidence of cytomegalovirus disease after autologous CD34-selected peripheral blood stem cell transplantation . Blood . 1999;94:4029–4035
  30. Kusnierz-Glaz CR , Still BJ , Amano M , et al.   Granulocyte colony-stimulating factor-induced comobilization of CD4− CD8− T cells and hematopoietic progenitor cells (CD34+) in the blood of normal donors . Blood . 1997;89:2586–2595
  31. Gutierrez-Delgado F , Holmberg L , Hooper H , et al.   Autologous stem cell transplantation for Hodgkin’s disease (busulfan, melphalan and thiotepa compared to a radiation-based regimen) . Bone Marrow Transplant . 2003;32:279–285
  32. Holmberg LA , Demirer T , Rowley S , et al.   High-dose busulfan, melphalan and thiotepa followed by autologous peripheral blood stem cell (PBSC) rescue in patients with advanced stage III/IV ovarian cancer . Bone Marrow Transplant . 1998;22:651–659
  33. Bensinger WI , Schiffman KS , Holmberg L , et al.   High-dose busulfan, melphalan, thiotepa and peripheral blood stem cell infusion for the treatment of metastatic breast cancer . Bone Marrow Transplant . 1997;19:1183–1189
  34. Marin GH , Menna ME , Bergna MI , et al.   Induction of anti-tumor activity following autologous stem cell transplantation (immunotherapeutic implications) . Transplant Proc . 2001;33:2004–2007
  35. Kennedy MJ , Vogelsang GB , Beveridge RA , et al.   Phase 1 trial of intravenous cyclosporine to induce graft-versus-host disease in women undergoing autologous bone marrow transplantation for breast cancer . J Clin Oncol . 1993;11:478–484
  36. Gryn J , Johnson E , Goldman N , et al.   The treatment of relapsed or refractory intermediate-grade non-Hodgkin’s lymphoma with autologous bone marrow transplantation followed by cyclosporine and interferon . Bone Marrow Transplant . 1997;19:221–226
  37. Yeager AM , Vogelsang GB , Jones RJ , et al.   Induction of cutaneous graft-versus-host disease by administration of cyclosporine to patients undergoing autologous bone marrow transplantation . Blood . 1992;79:3031–3035
  38. Tricot G , Vesole DH , Jagannath S , et al.   Graft-versus-myeloma effect (proof of principle) . Blood . 1996;87:1196–1198
  39. Verdonck LF , Lokhorst HM , Dekker AW , et al.   Graft-versus-myeloma effect in two cases . Lancet . 1996;347:800–801
  40. Vogelsang G , Bitton R , Piantadosi S , et al.   Immune modulation in autologous bone marrow transplantation (cyclosporine and gamma-interferon trial) . Bone Marrow Transplant . 1999;24:637–640
  41. Miura Y , Thoburn CJ , Bright EC , et al.   Cytolytic effector mechanisms and gene expression in autologous graft-versus-host disease (distinct roles of perforin and Fas ligand) . Biol Blood Marrow Transplant . 2004;10:156–170
  42. Schmaltz C , Alpdogan O , Horndasch KJ , et al.   Differential use of Fas ligand and perforin cytotoxic pathways by donor T cells in graft-versus-host disease and graft-versus-leukemia effect . Blood . 2001;97:2886–2895
  43. Reddy P , Teshima T , Kukuruga M , et al.   Interleukin-18 regulates acute graft-versus-host disease by enhancing Fas-mediated donor T cell apoptosis . J Exp Med . 2001;194:1433–1440
  44. Adams KM , Nelson JL . Microchimerism (an investigative frontier in autoimmunity and transplantation) . JAMA . 2004;291:1127–1131
  45. Adams KM , Lambert NC , Heimfeld S , et al.   Male DNA in female donor apheresis and CD34-enriched products . Blood . 2003;102:3845–3847
  46. Kollman C , Howe CW , Anasetti C , et al.   Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors (the effect of donor age) . Blood . 2001;98:2043–2051
  47. Verdijk RM , Kloosterman A , Pool J , et al.   Pregnancy induces minor histocompatibility antigen-specific cytotoxic T cells (implications for stem cell transplantation and immunotherapy) . Blood . 2004;103:1961–1964
  48. Flowers ME , Pepe MS , Longton G , et al.   Previous donor pregnancy as a risk factor for acute graft-versus-host disease in patients with aplastic anaemia treated by allogeneic marrow transplantation . Br J Haematol . 1990;74:492–496

PII: S1083-8791(05)00681-6

doi: 10.1016/j.bbmt.2005.10.011

Biology of Blood and Marrow Transplantation
Volume 12, Issue 2 , Pages 226-234 , February 2006

Article Tools